Share your videos with the world

Sign Up | Log In | Help  

Related Tags: c  r  bard  inc  bard  lifestent  vascular  stent  resilient  trial  results  lesions  superficial  fem  artery 
Search // superficial
Results 1-1 of 1 for ' superficial ' (0 seconds)
C. R. Bard, Inc. today announced the publication of RESILIENT trial results by Circulation: Cardiovascular Interventions showing the Bard LifeStent® Vascular Stent improved patency and reduced revascularization rates in patients with moderate-length lesions in the superficial femoral artery (SFA) and proximal popliteal artery compared to patients treated with percutaneous transluminal angioplasty (PTA). To view Multimedia News Release, go to
Categories // News and Politics 
Added: 4557 days ago by MultiVuVideo
Runtime: 4m15s | Views: 5231 | Comments: 0
Not yet rated



Page 1 of 1  |  Go to page   

About Us   |   Help  |   Advertise on ClipMoon   |   Terms of Use   |   Privacy Policy   |   Copyright   |   Contact   |   Link us   |   RSS 
Copyright © 2007-2022 All rights reserved.